This study is looking at Psilocybin-Assisted Therapy (PAT) to help UCSD physicians who are experiencing burnout. PAT combines a single 25 mg dose of psilocybin, a naturally occurring compound, with psychological support. Researchers want to see if this therapy is safe, practical, and can help reduce burnout symptoms. To join, you must be a UCSD faculty physician between 21 and 70 years old, have experienced burnout symptoms for over six months, and not have a history of serious mental illness or substance use disorder. The main goal is to measure changes in your well-being using the Stanford Professional Fulfillment Index (PFI) from when you start until 12 weeks after the study ends. This study is currently unclear on its recruitment status.

Study design

This is an open-label study, meaning both you and the researchers will know what treatment you are receiving. It involves a small group of 10 participants.

What's involved

You would participate in preparatory therapy sessions, receive a single dose of psilocybin, and then have post-treatment integration sessions.

Compensation

Not stated in the trial record.

Follow-up

Your well-being will be measured from enrollment until 12 weeks after the study ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.